Profile
Our mission in healthcare endows us with a distinct duty to not just act, but to engage wholeheartedly in sustainable and responsible development practices. Based on the latest available figures (FY 2025), the company shows revenue of 4.41B.
Industrie Pharmaceutique • MA0000012585
Borsalia tracks Akdital with its price, intraday chart, filings, and company-linked news on the Casablanca Stock Exchange.
Our mission in healthcare endows us with a distinct duty to not just act, but to engage wholeheartedly in sustainable and responsible development practices. Based on the latest available figures (FY 2025), the company shows revenue of 4.41B.
Akdital price, daily move, turnover, and session range are grouped at the top of the page for a quick public-market read.
Liquidity, spread, and turnover to judge tradability.
Peer comparisons with SOTHEMA and PROMOPHARM and related listed names.
Company-linked filings, news, and market context around Akdital.
Our mission in healthcare endows us with a distinct duty to not just act, but to engage wholeheartedly in sustainable and responsible development practices.
Direct exposure to the Industrie Pharmaceutique sector.
Verified shareholder structure available for this page.
Recent official issuer documents linked to the stock.
Automated news and release monitoring.
| Company | Price | 1D change | Market cap | P/E | Liquidity |
|---|---|---|---|---|---|
| 1.171,00 MAD | -0.43% | 16,6 Md MAD | -- | light |
 | 377,00 MAD | -0.53% | 2,9 Md MAD | -- | light |
 | 1.350,00 MAD | +0.00% | 1,4 Md MAD | -- | light |
 | 1.220,00 MAD | +0.00% | 1,2 Md MAD | -- | light |
 | 129,30 MAD | -0.54% | 7,8 Md MAD | -- | light |
 | 32,80 MAD | -0.58% | 13,2 Md MAD | -- | light |
Synthèse concise: Akdital (AKT) est un groupe privé de santé bien positionné au Maroc. Le snapshot FY2025 montre un chiffre d’affaires solide (4,413 MDH) et un EBITDA élevé, mais des incohérences entre postes essentiels (résultat net déclaré vs note interne; différences d’indicateurs d’exploitation). La structure financière affiche des capitaux propres ≈2,50 MMDH et un endettement net élevé (≈2,89 MMDH) — levier significatif. Valorisation de marché élevée (market cap ≈16,58 MMDH, PB ≈6,64). Dernier cours 1 171 MAD (30‑05‑2026). Données publiques récentes: partenariats d’accréditation et nomination d’un administrateur connu.
The Akdital quote is the entry point: last price, change, range, volume, and traded value. Before drawing a quick conclusion, compare that move with liquidity, recent chart behavior, and the role of AKT within Industrie Pharmaceutique. A single move may reflect real information, but it can also come from a thin order book or a session with limited turnover.
Listed filings help explain results, releases, notices, and events that may sit behind a price move. Recent news is a monitoring signal, but the stronger workflow is to open filings, check dates, and compare the content with the page metrics. Events and dividends should be read in the same context.
The displayed shareholder structure adds governance context, but it does not replace fundamentals, valuation, and peer comparison. Use comparable companies, financial indicators, and dividend history to separate a temporarily active stock from a company whose underlying data is changing. Borsalia keeps this page informational: no target price and no personalized recommendation.
For AKT, the strongest reading follows the same order every time: price and volume, chart, filings, events, fundamentals, shareholders, then sector comparison. This routine makes company pages comparable and prevents one visible module from dominating the read. If a tab looks sparse, treat it as a verification signal: it often means a publication is missing, a data field is not exploitable, or a consistency check is still open. Keep the same checklist when comparing peers so the conclusion is based on a repeatable method.
